Valuation: LanZhou Foci Pharmaceutical Co.,Ltd.

Market Cap 393.21Cr 59Cr 53Cr 49Cr 44Cr 83Cr 5.61TCr 84Cr 586.68Cr 232.06Cr 2.93TCr 221.18Cr 216.45Cr 9.29TCr P/E 2024
65.6x
P/E 2025 89.6x
Enterprise Value 345.31Cr 52Cr 46Cr 43Cr 39Cr 73Cr 4.92TCr 74Cr 515.21Cr 203.79Cr 2.58TCr 194.24Cr 190.09Cr 8.15TCr EV / Sales 2024
3.66x
EV / Sales 2025 4.3x
Free-Float
33.12%
Yield 2024
0.16%
Yield 2025 0.23%
1 day-0.26%
1 week-4.23%
Current month-6.78%
1 month-5.41%
3 months+3.22%
6 months-4.82%
Current year-10.88%
1 week 7.41
Extreme 7.41
8.09
1 month 7.41
Extreme 7.41
8.48
Current year 6.63
Extreme 6.63
11.02
1 year 6.63
Extreme 6.63
11.02
3 years 5.84
Extreme 5.84
11.85
5 years 5.84
Extreme 5.84
15.17
10 years 5.84
Extreme 5.84
15.17
Manager TitleAgeSince
Chief Executive Officer 62 06/04/2022
Director of Finance/CFO - 02/12/2022
Corporate Officer/Principal 52 01/02/2018
Director TitleAgeSince
Chairman 60 08/05/2014
Chairman 62 30/06/2017
Director/Board Member 54 12/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%-4.23%-14.54%-19.20% 59Cr
+0.45%+3.13%+54.96%+125.16% 1,13500Cr
+0.94%+4.93%+39.86%+78.72% 64TCr
+0.39%+1.44%+25.77%+97.48% 50TCr
+1.43%+4.31%+46.20%+67.12% 38TCr
-3.21%-2.10%+60.72%+33.22% 36TCr
-0.41%+2.64%+22.48%+49.82% 29TCr
+0.23%+3.66%+2.57%+23.69% 27TCr
+1.22%+4.63%+52.40%+64.85% 24TCr
+1.70%+3.67%+31.21%+102.15% 19TCr
Average +0.22%+2.16%+32.16%+62.30% 40.04TCr
Weighted average by Cap. +0.42%+2.84%+41.39%+83.59%

Financials

2024 2025
Net sales 98Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.4TCr 21Cr 146.25Cr 58Cr 731.05Cr 55Cr 54Cr 2.31TCr 92Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.31TCr 20Cr 136.6Cr 54Cr 682.8Cr 51Cr 50Cr 2.16TCr
Net income 6.01Cr 90.03L 80.5L 74.48L 67.44L 1.26Cr 86Cr 1.28Cr 8.96Cr 3.55Cr 45Cr 3.38Cr 3.31Cr 141.85Cr 4.92Cr 73.75L 65.95L 61.01L 55.24L 1.03Cr 70Cr 1.05Cr 7.34Cr 2.9Cr 37Cr 2.77Cr 2.71Cr 116.2Cr
Net Debt -36Cr -5.35Cr -4.79Cr -4.43Cr -4.01Cr -7.5Cr -509.19Cr -7.63Cr -53Cr -21Cr -266.33Cr -20Cr -20Cr -843.26Cr -48Cr -7.18Cr -6.42Cr -5.94Cr -5.38Cr -10Cr -683.01Cr -10Cr -71Cr -28Cr -357.24Cr -27Cr -26Cr -1.13TCr
Projected Income Statement - Annual - LanZhou Foci Pharmaceutical Co.,Ltd.
Logo LanZhou Foci Pharmaceutical Co.,Ltd.
Lanzhou Foci Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture of traditional Chinese medicine. The Company's main businesses include the research and development, production and sales of Chinese patent medicines and health products, cultivation and sales of Chinese medicinal materials, processing and sales of Chinese herbal medicines, production and sales of medical devices such as protective masks, and others. The Company's products include Fufang Huangqi Jianpi Oral Liquid, Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Shenrong Guben Huanshao Pills, donkey-hide gelatin, Chinese herbal medicine slices, and others. The Company's products cover categories and fields such as tonic, cold, gastrointestinal, gynecology, and tranquilizing sleep.
Employees
1,332
Date Price Change Volume
26/26/26 CN¥7.700 -0.26% 32,44,900
23/26/23 CN¥7.720 +0.13% 44,36,999
22/26/22 CN¥7.710 -2.41% 26,92,405
21/26/21 CN¥7.900 -1.00% 36,85,578
20/26/20 CN¥7.980 -0.75% 27,02,500
  1. Stock Market
  2. Stocks
  3. 002644 Stock